Postmarketing Surveillance Study of Prolia (Denosumab) in South Korea

First published 16/03/2017

Last updated 22/01/2021

EU PAS number:

EUPAS17915

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

01 20 01 Protocol Ver 1 0 2016-08-29 redacted

English (437.96 KB - PDF)View document

Study results

Study results

Prolia_Abstract_Final_18Dec2020

English (100.15 KB - PDF)View document

Study report

Other information